Microbiota and innate immunity in intestinal inflammation and neoplasia
- PMID: 23207600
- DOI: 10.1097/MOG.0b013e32835a670e
Microbiota and innate immunity in intestinal inflammation and neoplasia
Abstract
Purpose of review: This review focuses on recent advances and novel insights into the mechanistic events that may link commensal microbiota and host innate immunity in the pathophysiology of intestinal inflammation and neoplasia. Unanswered questions are discussed and future perspectives in the field are highlighted.
Recent findings: Commensal microbiota, host innate immunity, and genetics form a multidimensional network that controls homeostasis of the mucosal barrier in the intestine. Large-scale sequencing projects have begun to catalog the healthy human microbiome. Converging evidence suggests that alterations in the regulation of the complex host environment [e.g., dysbiosis and overgrowth of select commensal bacterial species, dietary factors, copresence of facultative pathogens (including viruses), and changes in mucus characteristics] may trigger aberrant innate immune signaling, thereby contributing to the development of intestinal inflammation and associated colon cancer in the susceptible individual. Genetically determined innate immune malfunction may create an inflammatory environment that promotes tumor progression (such as the TLR4-D299G mutation).
Summary: The next challenging steps to be taken are to decipher changes in the human microbiome (and virome) during well defined diseased states, and relate them to intestinal mucosal immune functions and host genotypes.
Similar articles
-
Innate immune signalling at intestinal mucosal surfaces: a fine line between host protection and destruction.Curr Opin Gastroenterol. 2008 Nov;24(6):725-32. doi: 10.1097/MOG.0b013e32830c4341. Curr Opin Gastroenterol. 2008. PMID: 19122523 Review.
-
Nod-like receptors in intestinal host defense: controlling pathogens, the microbiota, or both?Curr Opin Gastroenterol. 2013 Jan;29(1):15-22. doi: 10.1097/MOG.0b013e32835a68ea. Curr Opin Gastroenterol. 2013. PMID: 23132210 Review.
-
The colonic microbiota in health and disease.Curr Opin Gastroenterol. 2013 Jan;29(1):49-54. doi: 10.1097/MOG.0b013e32835a3493. Curr Opin Gastroenterol. 2013. PMID: 23041677 Review.
-
Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.Immunol Lett. 2004 May 15;93(2-3):97-108. doi: 10.1016/j.imlet.2004.02.005. Immunol Lett. 2004. PMID: 15158604 Review.
-
Commensal-innate immune miscommunication in IBD pathogenesis.Dig Dis. 2012;30(4):334-40. doi: 10.1159/000338120. Epub 2012 Jul 12. Dig Dis. 2012. PMID: 22796793 Review.
Cited by
-
Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota-Gut-Brain Axis.Front Endocrinol (Lausanne). 2021 Nov 8;12:748254. doi: 10.3389/fendo.2021.748254. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34819919 Free PMC article. Review.
-
Effect of Lactobacillus plantarum ACTT 8014 on 5-fluorouracil induced intestinal mucositis in Wistar rats.Exp Ther Med. 2020 Dec;20(6):209. doi: 10.3892/etm.2020.9339. Epub 2020 Oct 14. Exp Ther Med. 2020. PMID: 33149773 Free PMC article.
-
An Integrated Multi-Disciplinary Perspectivefor Addressing Challenges of the Human Gut Microbiome.Metabolites. 2020 Mar 6;10(3):94. doi: 10.3390/metabo10030094. Metabolites. 2020. PMID: 32155792 Free PMC article. Review.
-
Gut Microbiome and Colon Cancer: Role of Bacterial Metabolites and Their Molecular Targets in the Host.Curr Colorectal Cancer Rep. 2017 Apr;13(2):111-118. doi: 10.1007/s11888-017-0362-9. Epub 2017 Feb 22. Curr Colorectal Cancer Rep. 2017. PMID: 30337849 Free PMC article.
-
Influence of Microbiota on Intestinal Immune System in Ulcerative Colitis and Its Intervention.Front Immunol. 2017 Nov 28;8:1674. doi: 10.3389/fimmu.2017.01674. eCollection 2017. Front Immunol. 2017. PMID: 29234327 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials